Tentamus Group, a leading company in the food, pharmaceutical, cosmetics and agri-science industries, is delighted to announce a change in its management team from April 1, 2024. This change marks a significant milestone in the development of the company and reflects the commitment to growth and innovation of the entire group.
The current leaders and co-founders Dr. Jochen P. Zoller and Mr. Abgar Barseyten will now hand over their role as joint CEO's and move into their new positions as Chairman and Board Member respectively. They will focus on mergers and acquisitions (M&A) and continue to bring their proven market presence and strategic skills, providing significant contributions to exceeding Tentamus Group's growth targets and further strengthening its position in the market.
The newly designated CEO is Dr. Christian Rebhan, who has 20 years of strategic and operational experience in the life science sector.
With his ability to implement transformative strategies and inspire employees, Dr. Christian Rebhan is ideally positioned to lead the Tentamus Group into the next phase of growth.
"I am extremely excited to take on the position of CEO and to be part of such a dynamic and innovative team," emphasizes Dr. Rebhan. "I am determined to further the vision of the Tentamus Group and position our company as an industry leader."
Dr. Rebhan is an experienced executive with a background in management consulting and healthcare. For the past five years, he has been a member of the management team at Unilabs, a leading international provider of diagnostic services. He is characterized by an analytical view and a focus on profitable growth based on an inspiring and goal-oriented leadership culture. Prior to joining Unilabs, he worked as a Partner at Bain & Company, where he managed international mandates in the healthcare and private equity sectors. He began his professional career after studying medicine at the Universities of Heidelberg and LMU Munich and completed his education with an MBA at INSEAD in Fontainebleau and Singapore.
Dr. Jochen P. Zoller, Chairman of the Board has announced: "We are delighted to have Dr. Rebhan at Tentamus Group and wish him all the best on his and our journey together. I am sure that with his visionary leadership and unwavering commitment, he will take our company to new heights and achieve our common goals."
Dr. Jochen P. Zoller and Abgar Barseyten founded the company in 2011 and had a significant influence on it. Their decision to focus more on M&A reflects the Group's commitment to sustainable development and strategic expansion.
With a clear focus on innovation, growth and industry-leading performance, the Tentamus Group is ready to strengthen its position as a market leader and further expand the business.
For further information and inquiries please contact: hello@tentamus.com
The current leaders and co-founders Dr. Jochen P. Zoller and Mr. Abgar Barseyten will now hand over their role as joint CEO's and move into their new positions as Chairman and Board Member respectively. They will focus on mergers and acquisitions (M&A) and continue to bring their proven market presence and strategic skills, providing significant contributions to exceeding Tentamus Group's growth targets and further strengthening its position in the market.
The newly designated CEO is Dr. Christian Rebhan, who has 20 years of strategic and operational experience in the life science sector.
With his ability to implement transformative strategies and inspire employees, Dr. Christian Rebhan is ideally positioned to lead the Tentamus Group into the next phase of growth.
"I am extremely excited to take on the position of CEO and to be part of such a dynamic and innovative team," emphasizes Dr. Rebhan. "I am determined to further the vision of the Tentamus Group and position our company as an industry leader."
Dr. Rebhan is an experienced executive with a background in management consulting and healthcare. For the past five years, he has been a member of the management team at Unilabs, a leading international provider of diagnostic services. He is characterized by an analytical view and a focus on profitable growth based on an inspiring and goal-oriented leadership culture. Prior to joining Unilabs, he worked as a Partner at Bain & Company, where he managed international mandates in the healthcare and private equity sectors. He began his professional career after studying medicine at the Universities of Heidelberg and LMU Munich and completed his education with an MBA at INSEAD in Fontainebleau and Singapore.
Dr. Jochen P. Zoller, Chairman of the Board has announced: "We are delighted to have Dr. Rebhan at Tentamus Group and wish him all the best on his and our journey together. I am sure that with his visionary leadership and unwavering commitment, he will take our company to new heights and achieve our common goals."
Dr. Jochen P. Zoller and Abgar Barseyten founded the company in 2011 and had a significant influence on it. Their decision to focus more on M&A reflects the Group's commitment to sustainable development and strategic expansion.
With a clear focus on innovation, growth and industry-leading performance, the Tentamus Group is ready to strengthen its position as a market leader and further expand the business.
For further information and inquiries please contact: hello@tentamus.com
